Staccato Zaleplon Single Dose Pharmacokinetics
NCT00620620
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
UNKNOWN
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Inhaled placebo
DRUG:
Inhaled Zaleplon 0.5 mg
DRUG:
Inhaled Zaleplon 1 mg
DRUG:
Inhaled Zaleplon 2 mg
DRUG:
Inhaled Zaleplon 4 mg
Sponsor
Alexza Pharmaceuticals, Inc.